Baroda BNP Paribas Mutual Fund
← All mutual funds

Baroda BNP Paribas Health and Wellness Fund - Direct Plan - Growth Option

Baroda BNP Paribas Mutual Fund · Sectoral/Thematic · Direct · Growth

NAV · as of 11/09/2026

10.97

1D

-0.10%

1Y

+11.34%

Key stats

Expense ratio
0.61%
AUM
₹519.40 Cr
Launched
27/06/2025
Fund manager
Rohan Korde; Ankeet Pandya
Portfolio turnover
0.74%
Risk
Very High Risk
Min lump-sum
₹1,000
Min SIP
₹500/mo
Fresh lump-sum
Accepted
Fresh SIP
Accepted

NAV history

Baroda BNP Paribas Health and Wellness Fund - Direct Plan - Growth Option

13/08/2026 to 11/09/2026

O - H - L -

11.1210.8713/08/202611/09/2026
1W+0.64%
1M-0.11%
3M+7.50%
6M+16.31%
1Y+11.34%
MAX+9.53%

Top holdings

33 disclosed
  • 1.

    Sun Pharmaceuticals Industries Ltd

    Healthcare

    8.82%
  • 2.

    Torrent Pharmaceuticals Ltd

    Healthcare

    8.58%
  • 3.

    Divi's Laboratories Ltd

    Healthcare

    6.66%
  • 4.

    Lupin Ltd

    Healthcare

    6.46%
  • 5.

    Ipca Laboratories Ltd

    Healthcare

    5.72%
  • 6.

    Apollo Hospitals Enterprise Ltd

    Healthcare

    5.35%
  • 7.

    Laurus Labs Ltd

    Healthcare

    5.24%
  • 8.

    Fortis Healthcare Ltd

    Healthcare

    4.55%
  • 9.

    AstraZeneca Pharma India Ltd

    Healthcare

    4.05%
  • 10.

    Glenmark Pharmaceuticals Ltd

    Healthcare

    3.44%
  • 11.

    Dr. Lal PathLabs Ltd

    Healthcare

    3.12%
  • 12.

    Mankind Pharma Ltd

    Healthcare

    3.09%
  • 13.

    Aurobindo Pharma Ltd

    Healthcare

    3.04%
  • 14.

    Aster DM Quality Care Ltd Ordinary Shares

    Healthcare

    2.53%
  • 15.

    Zydus Lifesciences Ltd

    Healthcare

    2.47%
  • 16.

    Emcure Pharmaceuticals Ltd

    Healthcare

    2.46%
  • 17.

    Abbott India Ltd

    Healthcare

    2.41%
  • 18.

    Net Receivables / (Payables)

    2.41%
  • 19.

    Max Financial Services Ltd

    Financial Services

    2.27%
  • 20.

    Acutaas Chemicals Ltd

    Basic Materials

    2.15%
  • 21.

    Concord Biotech Ltd

    Healthcare

    2.05%
  • 22.

    Nephrocare Health Services Ltd

    Healthcare

    1.74%
  • 23.

    Metropolis Healthcare Ltd

    Healthcare

    1.46%
  • 24.

    Inventurus Knowledge Solutions Ltd

    Healthcare

    1.42%
  • 25.

    Ajanta Pharma Ltd

    Healthcare

    1.40%
  • 26.

    Gland Pharma Ltd

    Healthcare

    1.20%
  • 27.

    Cipla Ltd

    Healthcare

    1.13%
  • 28.

    Dr Reddy's Laboratories Ltd

    Healthcare

    1.11%
  • 29.

    Medplus Health Services Ltd

    Healthcare

    1.09%
  • 30.

    Clearing Corporation Of India Ltd

    0.98%
  • 31.

    Manipal Health Enterprises Ltd

    Healthcare

    0.96%
  • 32.

    Procter & Gamble Health Ltd

    Healthcare

    0.64%
  • 33.

    SBI Life Insurance Co Ltd

    -

Sector allocation

  • Healthcare92.19%
  • Unclassified3.39%
  • Financial Services2.27%
  • Basic Materials2.15%

Comparable peers

  • SBI Healthcare Opportunities Growth Direct Plan

    SBI Healthcare Opportunities (G) · ₹5.80 K Cr AUM

    1Y+21.41%
    3Y+24.25%
    -

  • UTI Healthcare Growth Direct Plan

    UTI Healthcare (G) · ₹1.44 K Cr AUM

    1Y+16.47%
    3Y+24.12%
    -

  • LIC MF Infrastructure Growth Direct Plan

    LIC MF Infrastructure (G) · ₹1.17 K Cr AUM

    1Y+12.15%
    3Y+23.06%
    -

  • Baroda BNP Paribas Health & Wellness Growth Direct Plan

    Baroda BNP Paribas Health & Wellness (G) · ₹519.40 Cr AUM

    1Y+11.34%
    3Y0.00%
    -

  • HDFC Transportation & Logistics Growth Direct Plan

    HDFC Transportation & Logistics (G) · ₹2.12 K Cr AUM

    1Y+9.75%
    3Y+24.94%
    -

Investment objective

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.

Scheme details

Scheme code
153604
Fund house
Baroda BNP Paribas Mutual Fund
Category
Open Ended
Type
Equity Scheme
Sub-category
Sectoral/Thematic
Plan
Direct
Return type
Growth
ISIN (Growth)
INF251K01VA5
ISIN (Div. Reinvest)
-
Tradable on exchange
No

Kuvera page